Filing Details
- Accession Number:
- 0001127602-16-068059
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2016-11-22 14:45:26
- Reporting Period:
- 2016-11-18
- Filing Date:
- 2016-11-22
- Accepted Time:
- 2016-11-22 14:45:26
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 882095 | Gilead Sciences Inc | GILD | Biological Products, (No Disgnostic Substances) (2836) | 943047598 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1174463 | W John Madigan | 333 Lakeside Drive Foster City CA 94404 | Yes | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2016-11-18 | 105,000 | $20.71 | 121,761 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2016-11-18 | 105,000 | $74.86 | 16,761 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Non-qualified Stock Option (Right to Buy) | Disposition | 2016-11-18 | 105,000 | $0.00 | 105,000 | $20.71 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 0 | 2017-05-09 | No | 4 | M | Direct |
Footnotes
- Options vested in full on May 9, 2007, the date of grant.
- Sale prices reported for the transactions reported here range from $74.55 to $75.18. Full information regarding the number of shares purchased or sold at each separate price will be provided to the SEC, the issuer or its shareowners upon request.
Billionaire Hedge Funds
